Autoinjectors Market Size – Quantitative Research By QYResearch Medical

The global auto-injectors market reported a large market size in 2022, which is expected to expand significantly in 2032 at a rapid revenue growth rate during the forecast period. Industry analysis indicates that demand for auto-injectors has been rising substantially, and its adoption across homecare settings and hospitals has been increasing in a parallel manner due to changing market trends and consumption patterns. These factors are expected to continue to support industry as well as market growth over the forecast period.

An auto-injector is a type of syringe with a spring-charged needle and pre-charged dosage of a drug. When pressed into the body with a sliding motion, the system triggers and releases measured dosage of a drug. Auto-injectors are preferred over traditional devices as they are more efficient and improved in terms of drug delivery. Auto-injectors have several advantages, such as reducing anxiety or phobia associated with the use of conventional needles, reducing instances of needle stick injuries, and accurate dose consistency. Drug delivery by auto-injectors is more controlled than manual injection.

Request a Sample@

Auto-injectors Market Dynamics

Increasing prevalence of anaphylactic shock, rising awareness about auto-injectors, and patient preference for self-injection are major growth-driving factors for the global auto-injectors market. Growing geriatric population worldwide is likely to drive market growth during the forecast period.

Auto-injectors are more effective and accurate than manual injection, and they are also less painful than syringes. These factors are contributing significantly to overall market growth. Innovations in device functions and development of cost-effective methods by key market players are further expected to boost market growth. Auto-injectors are disposable and reusable. Rheumatoid arthritis is a chronic autoimmune disease, and patients of rheumatoid arthritis using auto-injectors for treatment have been reported to experience better outcomes than those using manually administered injections.

Auto-injectors Market Regional Outlook

North America is the leading region in terms of revenue generation in the global auto-injectors market. It is expected to continue its domination over the market in the forecast period. This is due to advancements in medical technologies, presence of modern healthcare facilities and infrastructure, and rising awareness about auto-injectors among general population. Presence of a large population suffering from chronic diseases in the U.S is further driving market growth. The Asia-Pacific market is expected to grow at the fastest rate due to increasing cases of patients suffering from diabetes and anaphylaxis in highly populated countries in the region, such as India, China, Japan, Singapore, and Australia.

Auto-injectors Market: Competitive Landscape

The report contains an industry analysis of recent developments and trends in the global auto-injectors market and strategies adopted by key players operating in the market. It also includes information on collaborations, business contracts, mergers and acquisitions, and joint ventures.

Key Players Operating in Global Auto-injectors Market Are –

  • Amgen
  • Antares Pharma
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Johnson and Johnson
  • Mylan N.V.
  • Novartis AG
  • SHL Medical
  • Teva Pharmaceutical Industries Ltd
  • Ypsomed AG

Global Auto-injectors Market: Segmentation

The report consists of forecasts for the auto-injectors market at global, regional, and country levels. The report contains an analysis of market trends in each segment for the period 2023 to 2032. For this study, has segmented the global auto-injectors market on the basis of type, application, end user, and region as follows –

Type Outlook (Revenue, USD Million; 2023-2032) 

  • Disposable Auto-injectors
  • Reusable Auto-injectors

Application Outlook (Revenue, USD Million; 2023-2032)

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

End User Outlook (Revenue, USD Million; 2023-2032)

  • Home Care Settings
  • Hospitals & Clinics

Regional Outlook (Revenue, USD Million; 2023-2032)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Buy quantitative research Report at discounted price – USD 1500

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333



About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:


Leave a Comment

Your email address will not be published. Required fields are marked *